| scholarly article | Q13442814 |
| P2093 | author name string | Aronson D | |
| Rayfield EJ | |||
| Bloomgarden Z | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 528-535 | |
| P577 | publication date | 1996-03-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Potential mechanisms promoting restenosis in diabetic patients | |
| P478 | volume | 27 |
| Q24626337 | A comparative study of restenosis rates in bare metal and drug-eluting stents |
| Q36320035 | AGI-1067: a novel vascular protectant for prevention of restenosis |
| Q36320553 | Acute coronary syndromes and diabetes mellitus |
| Q35152084 | Acute coronary syndromes in patients with diabetes mellitus: diagnosis, prognosis, and current management strategies |
| Q73782302 | Acute myocardial infarction: are diabetics different? |
| Q42268600 | Aortic response to balloon injury in obese Zucker rats |
| Q36943352 | Are complex coronary lesions more frequent in patients with diabetes mellitus? |
| Q46922586 | Assessment of potential relationship between wall shear stress and arterial wall response after bare metal stent and sirolimus-eluting stent implantation in patients with diabetes mellitus |
| Q53326906 | Assessment of vascular response after drug-eluting stents implantation in patients with diabetes mellitus: an optical coherence tomography sub-study of the J-DESsERT. |
| Q35469793 | Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty |
| Q34876677 | Choosing a revascularization strategy in patients with diabetes and stable coronary artery disease: a complex decision |
| Q44003340 | Clinical and angiographic outcomes of diabetic patients after coronary stenting: a comparison of native vessel stent restenosis rates in different diabetic subgroups |
| Q73505857 | Coagulation and complement activation |
| Q45938400 | Comparison of coronary stent expansion by intravascular ultrasonic imaging in younger versus older patients with diabetes mellitus. |
| Q44136330 | Comparison of one-year outcomes following coronary artery stenting in diabetic versus nondiabetic patients (from the Enhanced Suppression of the Platelet IIb/IIIa Receptor With Integrilin Therapy [ESPRIT] Trial). |
| Q77549294 | Comparison of stenting with balloon angioplasty for lesions of small coronary vessels in patients with diabetes mellitus |
| Q37218736 | Controlled release from multilayer silk biomaterial coatings to modulate vascular cell responses |
| Q38217328 | Coronary artery bypass grafting versus drug-eluting stents in patients with severe coronary artery disease and diabetes mellitus: systematic review and meta-analysis |
| Q36355228 | Coronary artery disease and diabetes mellitus |
| Q51359901 | Coronary flow reserve in patients with diabetes mellitus and prediabetes. |
| Q74129551 | Coronary intervention in the diabetic patient: improved outcome following stent implantation compared with balloon angioplasty |
| Q51123831 | Cutting balloon angioplasty for the treatment of in-stent restenosis in diabetics: A matched comparison of 6 months' outcome with conventional balloon angioplasty. |
| Q42831038 | Darwin and the survival of the fittest in modern interventional cardiology. |
| Q41457652 | Determinants of coronary vascular disease in patients with type II diabetes mellitus and their therapeutic implications. |
| Q44204599 | Diabetes in patients undergoing coronary artery bypass grafting. Impact on perioperative outcome |
| Q34099605 | Diabetes mellitus and coronary heart disease--from prevention to intervention: Part II. |
| Q77700043 | Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement |
| Q35127904 | Does lipoprotein (a) level have a predictive value in restenosis after coronary stenting? |
| Q36381320 | Drug-coated balloons for the treatment of in-stent restenosis in diabetic patients: A review of currently available scientific data |
| Q38171868 | Drug-eluting stent outcomes in diabetes. |
| Q31102731 | Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study |
| Q46701610 | Effect of Paclitaxel-eluting versus sirolimus-eluting stents on coronary restenosis in Korean diabetic patients |
| Q73289490 | Effect of preintervention plaque burden on subsequent intimal hyperplasia in stented coronary artery lesions |
| Q36923284 | Effects of daily glucose fluctuations on the healing response to everolimus-eluting stent implantation as assessed using continuous glucose monitoring and optical coherence tomography. |
| Q73356327 | Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury |
| Q51496269 | Effects of improved metabolic control on platelet reactivity in patients with type 2 diabetes mellitus following coronary angioplasty. |
| Q90482279 | Effects of lowest-dose vs. highest-dose pitavastatin on coronary neointimal hyperplasia at 12-month follow-up in type 2 diabetic patients with non-ST elevation acute coronary syndrome: an optical coherence tomography analysis |
| Q51141661 | Effects on blood compatibility in vitro by combining a direct P2Y12 receptor inhibitor and heparin coating of stents. |
| Q33692952 | Endothelial PGC-1α mediates vascular dysfunction in diabetes. |
| Q37191036 | Essential role of Pin1 via STAT3 signalling and mitochondria-dependent pathways in restenosis in type 2 diabetes |
| Q35888976 | Evaluation of in-stent restenosis in the APPROACH trial (Assessment on the Prevention of Progression by Rosiglitazone On Atherosclerosis in diabetes patients with Cardiovascular History). |
| Q46645173 | Expression and function of receptors for insulin-like growth factor-I and insulin in human coronary artery smooth muscle cells |
| Q47361043 | Functional differences between healthy and diabetic endothelial cells on topographical cues |
| Q39885755 | Glycaemic control and restenosis after percutaneous coronary interventions in patients with diabetes mellitus: a report from the Insulin Diabetes Angioplasty study. |
| Q40048851 | Glycemic Control in Coronary Revascularization |
| Q87199739 | Glycosylated hemoglobin levels and clinical outcomes in diabetic patients receiving percutaneous coronary interventions: A meta-analysis of cohort studies |
| Q36441977 | How to revascularize patients with diabetes mellitus: bypass or stents and drugs? |
| Q51553787 | Hyperinsulinemia during oral glucose tolerance test is associated with increased neointimal tissue proliferation after coronary stent implantation in nondiabetic patients: a serial intravascular ultrasound study. |
| Q44518607 | Impact of diabetes mellitus on long-term clinical outcomes of patients on chronic hemodialysis after percutaneous coronary intervention |
| Q32067074 | In-stent restenosis: the Washington Hospital Center experience |
| Q74062478 | Increased thrombus formation relates to ambient blood glucose and leukocyte count in diabetes mellitus type 2 |
| Q74534896 | Influence of diabetes on mortality and morbidity: off-pump coronary artery bypass grafting versus coronary artery bypass grafting with cardiopulmonary bypass |
| Q73782322 | Influence of treatment modality on angiographic outcome after coronary stenting in diabetic patients: a controlled study |
| Q46120002 | Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial |
| Q44517896 | Intimal hyperplasia following carotid endarterectomy in an insulin-resistant rat model |
| Q58145267 | Intravascular ultrasound observations of atherosclerotic lesion formation and restenosis in patients with diabetes mellitus |
| Q43016772 | Is surgery still the preferred option for coronary revascularisation in diabetics with multivessel coronary disease? |
| Q92815290 | Liraglutide Inhibits Endothelial-to-Mesenchymal Transition and Attenuates Neointima Formation after Endovascular Injury in Streptozotocin-Induced Diabetic Mice |
| Q50901002 | Long-term benefits of internal thoracic artery-coronary artery bypass in Japanese patients. |
| Q73308440 | Long-term outcome of coronary balloon angioplasty in diabetic patients |
| Q39727135 | Long-term outcome of early percutaneous coronary intervention in diabetic patients with acute coronary syndrome: insights from the BASE ACS trial. |
| Q77530104 | Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina |
| Q33996007 | Management of coronary artery disease: therapeutic options in patients with diabetes |
| Q47142994 | Maturation of arteriovenous fistula: Analysis of key factors. |
| Q46775757 | Microembolization and myonecrosis during elective percutaneous coronary interventions in diabetic patients: an intracoronary Doppler ultrasound study with 2-year clinical follow-up. |
| Q74780017 | Midterm angiographic outcome of single-vessel intracoronary stent placement in diabetic versus nondiabetic patients: a matched comparative study |
| Q35772244 | Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes |
| Q37827749 | Optimal treatment for coronary artery disease in patients with diabetes: percutaneous coronary intervention, coronary artery bypass graft, and medications |
| Q28193664 | Optimizing the diabetic formulary: beyond aspirin and insulin |
| Q74523226 | Outcomes in diabetics undergoing revascularization: the long and the short of it |
| Q35813673 | Percutaneous coronary intervention in diabetics |
| Q38068350 | Percutaneous versus surgical interventions for coronary artery disease in those with diabetes mellitus |
| Q74694147 | Predictive value of preprocedural fibrinogen concerning coronary stenting |
| Q57606058 | Predictors of Restenosis After Coronary Stent Implantation |
| Q35149725 | Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus |
| Q43045641 | Predictors of restenosis after percutaneous coronary intervention using bare-metal stents: a comparison between patients with and without dysglycemia. |
| Q78192649 | Primary stenting in acute myocardial infarction: influence of diabetes mellitus in angiographic results and clinical outcome |
| Q37680567 | Relationship between extent and complexity of coronary artery disease and different left ventricular geometric patterns in patients with coronary artery disease and hypertension. |
| Q73344123 | Restenosis after coronary placement of various stent types |
| Q78106212 | Restenosis, late vessel occlusion and left ventricular function six months after balloon angioplasty in diabetic patients |
| Q34793647 | Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting |
| Q36092782 | Role of CABG in the management of obstructive coronary arterial disease in patients with diabetes mellitus |
| Q92340460 | Serum cystatin C levels relate to no-reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction |
| Q47734969 | Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients |
| Q45250174 | Short and long-term outcome in diabetic patients with acute myocardial infarction in the invasive era. |
| Q30312070 | Stent restenosis and the use of drug-eluting stents in patients with diabetes mellitus |
| Q42950348 | The Effects of Acarbose Treatment on Intimal Hyperplasia in a Rat Carotid Endarterectomy Model of Diet-Induced Insulin Resistance |
| Q37140243 | The Impact of Type 2 Diabetes on the Efficacy of ADP Receptor Blockers in Patients with Acute ST Elevation Myocardial Infarction: A Pilot Prospective Study. |
| Q35584004 | The Role of Glycoprotein IIb/IIIa-Receptor Antagonists in Diabetics |
| Q77313110 | The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation |
| Q44655646 | The neointimal response to endovascular injury is increased in obese Zucker rats |
| Q36748161 | Therapy insight: diabetes and drug-eluting stents |
| Q73081815 | Tissue characteristics of restenosis after percutaneous transluminal coronary angioplasty in diabetic patients |
| Q73193141 | Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: a serial intravascular ultrasound study |
| Q26772996 | Type 2 Diabetes and ADP Receptor Blocker Therapy |
| Q28073031 | Understanding and managing in-stent restenosis: a review of clinical data, from pathogenesis to treatment |
| Q50908775 | Usefulness of the CHA2DS2-VASc Score in Predicting In-Stent Restenosis Among Patients Undergoing Revascularization With Bare-Metal Stents. |
| Q41556867 | What cardiologists need to know about diabetes. |
| Q73587523 | [A comparison of the clinical and angiographic evolution of diabetic and nondiabetic patients treated by conventional angioplasty versus stent implantation in native coronary arteries] |
| Q83182149 | [Diabetes and coronary stent implantation: experience from a reference center in interventional cardiology] |
| Q54004598 | [Diabetes mellitus, inflammation and coronary atherosclerosis: current and future perspectives] |
| Q82389746 | [Femoral superficial artery angioplasty: long term results, initial predictive factors. 101 patients] |
Search more.